Stock listing
BOATS:APUS Apimeds Pharmaceuticals US, Inc. Stock
US listing (BOATS) of Apimeds Pharmaceuticals US, Inc. · home listing NYSE American:APUS
Follow Apimeds Pharmaceuticals US, Inc. into a list and get an email when it puts out news.
Home listing price · AMEX:APUS
$2.89 USD -0.12 (-4.0%)
Close on Nov 2, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:APUS
- Day range
- $2.78 – $3.02 USDNov 2, 2026
- Volume
- 38,230 sharesNov 2, 2026
- Market cap
- $4.36M USDAt the close on Nov 2, 2026 · price × 1.51M shares outstanding
- 52-week range
- $1.51 – $59.70 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $21.44M USDMedian day 66,000 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:APUS · Home | $2.89 USD | -0.12 (-4.0%) | 38,230 | $3.01 | $3.02 | $2.78 | $3.01 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · AMEX:APUS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.89 | -0.12 | -4.0% | $3.01 | $3.02 | $2.78 | 38,230 | |
| $3.01 | -0.20 | -6.2% | $3.11 | $3.11 | $2.84 | 20,052 | |
| $3.21 | +0.14 | +4.6% | $2.89 | $3.21 | $2.83 | 48,752 | |
| $3.07 | +0.02 | +0.7% | $2.39 | $3.095 | $2.39 | 68,288 | |
| $3.05 | +0.155 | +5.4% | $2.90 | $3.05 | $2.65 | 143,086 | |
| $2.895 | +0.005 | +0.2% | $2.92 | $3.06 | $2.713 | 29,730 | |
| $2.89 | -0.27 | -8.5% | $3.07 | $3.175 | $2.81 | 35,400 | |
| $3.16 | -0.09 | -2.8% | $3.14 | $3.25 | $3.06 | 42,300 | |
| $3.25 | -0.16 | -4.7% | $3.51 | $3.57 | $3.005 | 128,000 | |
| $3.41 | -0.09 | -2.6% | $3.43 | $3.55 | $3.21 | 66,000 | |
| $3.50 | -0.54 | -13.4% | $3.92 | $3.95 | $3.40 | 101,700 | |
| $4.04 | -0.35 | -8.0% | $4.16 | $4.35 | $3.90 | 43,200 | |
| $4.39 | -0.19 | -4.1% | $4.25 | $4.415 | $4.00 | 109,000 | |
| $4.58 | -0.04 | -0.9% | $4.60 | $4.81 | $4.25 | 235,300 | |
| $4.62 | -0.58 | -11.2% | $4.87 | $4.91 | $4.26 | 339,800 | |
| $5.20 | +0.18 | +3.6% | $5.43 | $6.036 | $4.971 | 1,394,300 | |
| $5.02 | -0.49 | -8.9% | $5.54 | $5.72 | $4.40 | 3,346,300 | |
| $5.51 | -1.54 | -21.8% | $6.43 | $6.496 | $5.21 | 1,112,800 | |
| $7.05 | -0.08 | -1.1% | $8.00 | $9.84 | $6.86 | 22,395,400 | |
| $7.13 | +2.54 | +55.3% | $4.91 | $8.39 | $4.71 | 43,838,600 | |
| $4.59 | +1.37 | +42.5% | $4.99 | $5.83 | $4.21 | 33,787,400 | |
| $3.22 | -0.88 | -21.5% | $4.10 | $4.16 | $3.10 | 138,400 | |
| $4.10 | -0.90 | -18.0% | $4.90 | $5.09 | $4.10 | 145,800 | |
| $5.00 | -0.02 | -0.4% | $5.04 | $5.25 | $4.72 | 190,100 | |
| $5.02 | -1.37 | -21.4% | $6.17 | $6.17 | $4.63 | 762,100 | |
| $6.39 | -0.86 | -11.9% | $6.33 | $6.50 | $5.56 | 858,800 | |
| $7.25 | +2.33 | +47.4% | $8.32 | $9.14 | $5.39 | 37,114,300 | |
| $4.92 | +2.63 | +114.8% | $6.99 | $8.74 | $4.61 | 87,850,200 | |
| $2.29 | +0.44 | +23.8% | $1.81 | $2.30 | $1.745 | 152,500 | |
| $1.85 | +0.18 | +10.8% | $1.65 | $1.999 | $1.613 | 132,400 | |
| $1.67 | -0.10 | -5.6% | $1.72 | $1.865 | $1.67 | 671,000 | |
| $1.77 | +0.10 | +6.0% | $1.68 | $2.10 | $1.63 | 1,335,500 | |
| $1.67 | +0.07 | +4.4% | $1.73 | $1.92 | $1.60 | 83,900 | |
| $1.60 | -0.04 | -2.4% | $1.71 | $1.71 | $1.51 | 64,300 | |
| $1.64 | -0.45 | -21.5% | $2.11 | $2.11 | $1.60 | 66,200 | |
| $2.09 | -0.015 | -0.7% | $2.39 | $2.39 | $2.025 | 29,800 | |
| $2.105 | -0.065 | -3.0% | $2.16 | $2.26 | $2.09 | 20,700 | |
| $2.17 | -0.12 | -5.2% | $2.26 | $2.47 | $2.12 | 40,600 | |
| $2.29 | -0.01 | -0.4% | $2.30 | $2.35 | $2.17 | 29,500 | |
| $2.30 | -0.12 | -5.0% | $2.40 | $2.405 | $2.25 | 17,421 | |
| $2.42 | -0.09 | -3.6% | $2.49 | $2.60 | $2.42 | 24,400 | |
| $2.51 | -0.12 | -4.6% | $2.66 | $2.71 | $2.40 | 50,600 | |
| $2.63 | -0.91 | -25.7% | $3.17 | $3.38 | $2.51 | 84,100 | |
| $3.54 | -0.34 | -8.8% | $3.87 | $3.87 | $3.41 | 29,200 | |
| $3.88 | +0.01 | +0.3% | $4.09 | $4.09 | $3.73 | 8,200 | |
| $3.87 | -0.08 | -2.0% | $4.10 | $4.10 | $3.861 | 9,100 | |
| $3.95 | -0.65 | -14.1% | $4.63 | $4.81 | $3.737 | 172,200 | |
| $4.60 | -0.37 | -7.4% | $4.74 | $4.99 | $4.358 | 230,135 | |
| $4.97 | +0.22 | +4.6% | $4.78 | $5.35 | $4.65 | 49,100 | |
| $4.75 | -0.09 | -1.9% | $4.34 | $4.75 | $4.34 | 15,900 | |
| $4.84 | +0.45 | +10.3% | $4.30 | $5.43 | $4.175 | 559,500 | |
| $4.39 | 0.00 | 0.0% | $4.23 | $4.50 | $4.091 | 17,200 | |
| $4.39 | +0.39 | +9.7% | $3.88 | $4.55 | $3.69 | 23,000 | |
| $4.00 | -0.28 | -6.5% | $3.99 | $4.30 | $3.85 | 38,200 | |
| $4.28 | -0.27 | -5.9% | $3.45 | $4.30 | $3.39 | 1,617,000 | |
| $4.55 | -0.15 | -3.2% | $4.72 | $4.93 | $4.55 | 21,300 | |
| $4.70 | +0.04 | +0.9% | $4.37 | $4.99 | $4.37 | 52,400 | |
| $4.66 | +0.03 | +0.6% | $4.46 | $4.73 | $4.36 | 311,300 | |
| $4.63 | +0.39 | +9.2% | $4.47 | $4.63 | $4.285 | 6,100 | |
| $4.24 | +0.01 | +0.2% | $4.39 | $4.61 | $4.23 | 7,700 | |
| $4.23 | -0.60 | -12.4% | $4.75 | $4.815 | $4.23 | 8,300 | |
| $4.83 | +0.18 | +3.9% | $4.69 | $4.89 | $4.547 | 6,800 | |
| $4.65 | -0.27 | -5.5% | $4.77 | $5.155 | $4.65 | 16,900 | |
| $4.92 | +0.07 | +1.4% | $4.90 | $5.43 | $4.659 | 18,600 | |
| $4.85 | -0.30 | -5.8% | $5.18 | $5.30 | $4.83 | 23,600 |
- Ticker
- BOATS:APUS
- Asset type
- Stock
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 3, 2026
IBN Announces CryptoCurrencyWire Audio Production Featuring Dr. Vin Menon, CEO of MindWave Innovations Inc.
Latest news
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering
Sep 14, 2026
Closed $2.09 (-0.7%) on Sep 14, 2026
MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October
Jul 28, 2026
Closed $8.00 (+27.2%) on Jul 28, 2026
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
May 5, 2026
Closed $30.00 (+59.6%) on May 5, 2026
Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
May 4, 2026
Closed $18.80 (0.0%) on May 4, 2026
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
Mar 25, 2026
Closed $17.50 (+2.3%) on Mar 25, 2026
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS: 006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
Mar 24, 2026
Closed $17.10 (-12.3%) on Mar 24, 2026
Apimeds Pharmaceuticals and Lokahi Therapeutics Announce FDA Type C Meeting Scheduled for LT-100
Feb 12, 2026
Closed $11.00 (-24.1%) on Feb 12, 2026
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
Feb 11, 2026
Closed $11.00 (-24.1%) on Feb 12, 2026
Decks
Investor Presentation (July 2025)
Investor deck · 24 slides · July 2025
IPO Roadshow (February 2025)
IPO roadshow · 30 slides · Feb 10, 2025
Apimeds Pharmaceuticals US, Inc. on 6ix
- News releases
- 12 in the last 12 months · 20 in all · newest Nov 3, 2026 · oldest 2025
- Decks
- 2 decks · latest July 2025
Where Apimeds Pharmaceuticals US, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:APUS · Home listing | NYSE American | United States | USD |
| BOATS:APUS · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Apimeds Pharmaceuticals US, Inc.